🇰🇷 Ninlaro in South Korea

Ninlaro (IXAZOMIB) regulatory status in South Korea.

Marketing authorisations

MFDS

  • Status: likely_approved

MFDS

  • Status: likely_approved

Ninlaro in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Ninlaro approved in South Korea?

Yes. MFDS has authorised it; MFDS has authorised it.

Who is the marketing authorisation holder for Ninlaro in South Korea?

Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.